Best Savings Accounts in Singapore to Park Your Money (2021)

SingSaver team
·8-min read

Banks in Singapore have all lowered their savings account interest rates since COVID-19. Which begs the question: which savings account should you stash your cash in now?

Before COVID-19 struck, the average salaried worker could easily earn about 1.85% to 2% a year on high-interest savings accounts such as DBS Multiplier and UOB One.

But economic pressures have caused banks to lower their deposit interest rates. The ‘new normal’ savings accounts interest rate has fallen to about 1% to 1.6% instead — and that’s for the high-interest savings accounts.

To save you the trouble of looking through all these new interest rates, here’s an easy and up-to-date comparison of the best savings accounts in Singapore. Interest rates are valid from December 2020 onwards.

Best savings accounts for salaried workers

Salaried employees in Singapore are basically spoilt for choice when it comes to high-interest savings accounts. Almost every bank has a savings account that pays bonus interest for crediting your salary and spending on their credit cards.

Let’s find out how much interest an average Joe can get on his $10,000 savings, assuming a take-home pay of $3,500 and monthly credit card spending of $500. 

Savings account

Interest rate

How to maximise

Minimum balance

BOC SmartSaver

1%

– Pay 3 bills (min. $30) to get an extra 0.30%
– High earners (min. $6,000 salary) get an extra 0.50%

$1,500

DBS Multiplier Account

0.4%

– No min. salary or credit card spending, as long as they add up to $2,000
– Bump up your interest rate to the next tier with a DBS home loan

No min. balance until age 29 (subsequently $3,000)

UOB One Account

0.50%

– Pair with UOB One Card for cashback

$1,000

Standard Chartered Bonus$aver

0.38%

– Pay 3 bills (min. $50) to increase by 0.07%

$3,000

OCBC 360 Account

0.55%

– Increase monthly balance by $500 to bump up your interest by 0.2%

$3,000

Winner: BOC SmartSaver Account

There used to be a three-way fight between DBS Multiplier, UOB One and OCBC 360 accounts.

But ever since all three local banks reduced their interest rates (the latest round being DBS Multiplier and UOB One updates from August 2020 onwards), the DBS Multiplier account is the current ‘winner’.

We like that there is no minimum credit card spend or salary credit (as long as both add up to at least $2,000).

You can bump up your transaction total easily by opting for a DBS home loan (your cash + CPF monthly payments will count towards it). Now that bank interest rates are low, it’s not a bad idea to refinance and reduce your monthly expenses anyway.

However, DBS announced on 1 December 2020 that it too would have to further slash the Multiplier account’s interest rates due to the economic climate. This will take effect on 1 January 2021. Considering the same situation listed above, you will only be generating an interest rate of 0.4% p.a.

Unfortunately, this brings the DBS Multiplier account below the other accounts on the list, with the exception of Standard Chartered’s Bonus$aver account. Make hay while you still can and start considering other options out there.

Compare DBS Credit Cards

Worth considering: BOC SmartSaver Account

If you have a take-home salary of more than $6,000, you might want to consider Bank of China’s SmartSaver account. You can get 0.8% just for salary credit and spending $500 on your credit card. That’s double the DBS Multiplier account’s rates from January 2021 onwards.

But BOC has not updated its interest rates since August 2020, so who knows how long the high interest rates would last?

Best savings accounts without salary credit

Those without regular salaries — freelancers, gig workers, landlords, retirees, stay-at-home parents — need not be left out of the savings account game. But you might need to be creative with how you earn bonus interest with your account.

For simplicity’s sake, let’s assume you are a freelance writer. You don’t have a regular paycheck, but you do spend on your credit card, and you have bills to pay like anyone else. How much can you earn on your $10,000 savings stash?

Savings account

Interest rate

How it works

Minimum balance

Maybank Save Up Programme

Up to 3%

– Spend $500 + GIRO (min. $300) for 1%
– Add on insurance or investment to get 3%
– Starts from $5,000 annual premium for insurance

No min. balance until age 25 (subsequently $1,000)

Citi InterestPlus Account (applications ceased from 1 Aug 2020 onwards)

Up to 2.55%

– Spend $25 on credit card + insure OR invest to earn 1.35%
– Spend, insure AND invest to earn 2.55%
– Min. $250 a month or $25,000 lump sum for insurance or investment

None, but maintain min. $5,000 for better interest rates

Standard Chartered Bonus$aver

Up to 2.5%

– Spend > $2000 + pay 3 bills to earn 0.7%
– Invest in unit trust (min. $30,000) for extra 0.9%
– Buy insurance (min. $12,000) for extra 0.9%
– You can stack insurance + investment bonus interest

$3,000

OCBC 360 Account

Up to 0.9%

– Step up monthly balance by $500 to earn 0.1%
– Step up $500 AND insure or invest for extra 0.5%
– Starts from $2,000 annual premium for insurance

$3,000

UOB One Account

Up to 2.5%

– Spend $500 + pay 3 bills (no min.)
– Highest interest rate with no need to insure or invest

$1,000

Winner: UOB One Account

Yes, the UOB One account’s 0.5% interest rate for the first $15,000 puts it at the bottom of the list.

But it is the only one with simple, attainable requirements. Just spend $500 on your UOB credit card and pay three bills by GIRO (no minimum amount), and you’re done.

There is no need to insure or invest with the same bank, and the low minimum balance makes it appropriate for these lean times.

Switching to the UOB One account? You’ll need to pick up a UOB credit card to pair it with.

Compare UOB Credit Cards

Worth considering: Maybank Save Up Programme

If you don’t mind putting some cash in insurance and/or investments, the Maybank Save Up Programme is worth looking into. Pick any three transaction types to get 2.75% bonus interest on top of the base interest rate, adding up to close to 3%.

Spend $500 on a Maybank credit card, pay bill(s) by GIRO (minimum $300 in total), and you’re two-thirds of the way there.

Compare Maybank Credit Cards

For the last one, you can insure with Maybank (min. $5,000 annually) or buy a unit trust (min. $25,000). If you happen to need a home, car, renovation or education loan, those count as eligible transactions too.

Bonus: Best zero-effort savings accounts

We get it. Not everyone is keen to hit minimum spending requirements or monitor their account balance every month.

If you’re a lazy saver, or simply want a second account to complement your primary high-interest savings account, here are some great bank accounts that reward you for doing nothing.

Savings account

Interest rate

How it works

Minimum balance

POSB SAYE Account

Up to 2%

– Commit to regular monthly savings (you specify the amount)
– Must not withdraw for 2 years
– No age limit

No minimum

Standard Chartered JumpStart

0.4%

– No action required
– Capped at $20,000
– Open to 18 to 26 years old only

No minimum

OCBC Bonus+ Savings Account

0.5%

– Increase balance by $500 every month
– To earn interest, do not withdraw

$3,000

UOB Stash Account

1%

– Stash $100,000 to earn 0.8%
– Any amount above $100,000 earns 0.05%
– To earn interest, maintain or increase your account balance

$1,000

CIMB FastSaver

0.75%

– No action required
– 0.75% on $100,000 savings
– For savings above $100,000, you earn 0.3% p.a.

$1,000

You’ll notice that some of these savings accounts require you to not touch the funds in order to earn the advertised interest rate. If that’s the case, you might also want to consider a fixed deposit account.

Should you switch savings accounts?

If you have a lot of savings in your account, you’re probably itching to take action and switch banks. But do consider a wait-and-see approach for the next few months as we expect more interest rate cuts to occur.

Banks do change their interest rates every now and then, so it’s best to keep an eye on such things. Stay up to date and compare savings accounts easily with SingSaver.

Compare Best Savings Accounts

Read these next:
The Differences Between Bank Account Types You Need to Know
When Should You Open A Second Bank Account?
How Much Savings Should I Have At 35 In Singapore?
Fixed Deposits in Singapore: Complete 2020 Guide
7 Good Reasons to Change Your Savings Account

The post Best Savings Accounts in Singapore to Park Your Money (2021) appeared first on SingSaver Blog - We Compare, You Save.

Latest stories

  • Transgender student says school barred her again; considering poly route

    The school in the case of the transgender student, which has gone viral online, has allegedly barred the student from attending classes again.

  • China sanctions Pompeo, Trump officials for violating 'sovereignty'

    China said Wednesday it was sanctioning more than two dozen members and ex-officials in former president Donald Trump's government, including his secretary of state Mike Pompeo, for violating the country's "sovereignty" by making "crazy" policy moves.

  • Backlash to Chinese actress Zheng Shuang’s surrogacy scandal: ‘definitely not innocent’, authorities say, while brands distance themselves

    The backlash continues full throttle.Two days after popular Chinese actress Zheng Shuang was accused by her former partner, producer Zhang Heng, of abandoning their two children born to US-based surrogate mothers, Chinese authorities and a host of commercial brands linked to Zheng have reacted to the controversy.Zheng’s surrogacy used a legal loophole and was “definitely not innocent”, the Central Political and Legal Affairs Commission of the Communist Party of China said on Wednesday.Get the latest insights and analysis from our Global Impact newsletter on the big stories originating in China.“Surrogacy is banned in China as it uses women’s uteruses as a tool and sells life as a commercial product,” the commission’s post on Weibo, China’s Twitter-like service, said. “As a Chinese citizen, the act of travelling to the US on a legal loophole is not abiding the law.”China’s state broadcaster CCTV also commented on Weibo that “surrogacy is banned in China because it overlooks life”, before going on to call the practice “trampling the bottom line [of human morality]”.Fashion brand Prada, who had signed a contract with Zheng just eight days before the news broke, announced it would drop her as its ambassador. Magazines that Zheng had cooperated with, including Modern Weekly and the Chinese version of Harper’s Bazaar, deleted previous social media posts that promoted her.Other brands, including Chinese cosmetics brand Chioture, London-based jewellery brand Lola Rose and hair care brand Aussie, have distanced themselves from Zheng, announcing on Weibo that their contracts with her have already ended and they are not working with her at present.The Huading Awards – China’s equivalent to America’s People’s Choice Awards – announced it will renounce Zheng’s “best actress in a modern TV series” award from 2016 and “top 10 favorite TV stars” award from 2014. Netizens also demanded online that reality shows she currently features in, and films she is scheduled to appear in, drop the actress.Other celebrities and organisations that had previous associations with surrogacy have also come under intense public scrutiny.Blued, a Chinese gay social app, promptly took offline a section that helped users set up services with surrogacy firms overseas, according to Lanjinger, a finance news platform.Netizens also condemned movie star Xu Jinglei after a previous video interview was reposted in which she said she was prepared to use surrogacy when she’s ready to have a child.“It’s quite normal, lots of people around me do it … I’ve introduced many friends to hospitals,” she said in the video.On Monday, Zhang accused Zheng of abandoning their two children born to US-based surrogate mothers after the couple’s relationship ended before the children were born over a year ago. In a voice recording provided by one of Zhang’s friends to Chinese platform NetEase Entertainment, in which Zheng, Zhang and their parents allegedly discussed what to do with the then-unborn children, Zheng’s father suggested that they abandon the children at the hospital, while Zheng expressed annoyance that they could not be aborted as they had been in the womb for seven months.The scandal reignited debates over surrogacy laws in China.A ban of the practice is not technically written in legal codes, but the Ministry of Health has prohibited surrogacy in the country and other government ministries previously launched crackdowns against the practice.Underground businesses still exist, however, where agents set clients up with black-market surrogates in China as well as help them travel overseas to where surrogacy is legal, including some states in the US.There is now a public debate on whether there needs to be an overall ban and even on making the practice a criminal offence.More from South China Morning Post: * Zhang Ziyi follows Jackie Chan, Tom Cruise in playing a character much younger than she is, but fans and critics are not impressed * Chinese viewers divided over film about surrogacy, illegal in China but which thrives via underground networksThis article Backlash to Chinese actress Zheng Shuang’s surrogacy scandal: ‘definitely not innocent’, authorities say, while brands distance themselves first appeared on South China Morning PostFor the latest news from the South China Morning Post download our mobile app. Copyright 2021.

  • World’s rich fled Alibaba after monopoly probe, Citi says

    Wealthy investors rushed to offload stock in Alibaba Group Holding after China began an investigation into alleged monopolistic practices at Jack Ma’s internet giant, according to Citigroup Inc.’s private bank.

  • 40 new COVID cases in S'pore; 3 of 4 in community form new cluster

    The Ministry of Health (MOH) confirmed 40 new COVID-19 cases in Singapore on Wednesday (20 January), taking the country’s total case count to 59,197.

  • Philippines Allows Sinovac to Hold COVID-19 Vaccine Trials

    The Philippines has allowed China’s Sinovac Biotech Ltd. to hold clinical trials in the Southeast Asian nation for its coronavirus vaccine, which President Rodrigo Duterte prefers to be inoculated with, officials said.

  • Coronavirus: is China ready for the mRNA vaccine revolution?

    When the quest for a coronavirus vaccine began, China invested big in what it saw as the safest bet – inactivated vaccines.State-owned Sinopharm and private company Sinovac worked with government-affiliated labs to work around the clock to design inactivated viruses while construction started on biosecure facilities to meet anticipated demand.But then came the results from developers of an alternative technology called mRNA.Get the latest insights and analysis from our Global Impact newsletter on the big stories originating in China.The stellar efficacy data from clinical trials by mRNA vaccine pioneers Pfizer-BioNTech and Moderna sent shock waves through the industry, prompting a reassessment of the approach.A top Chinese health official has since urged companies to look again at the new technology while other domestic players are already making the pivot to embrace what they say is a new vaccine era. What are the coronavirus mRNA vaccines and how do they work?In November, soon after Pfizer-BioNTech and Moderna announced an interim efficacy rate of more than 90 per cent for their candidates, the head of the Chinese Centre for Disease Control and Prevention told the country’s vaccine executives that mRNA technology could revolutionise the industry and they should be ready.Addressing the 4,000 people at the China Biological Products Annual Conference in Zhuhai in southern China, George Gao Fu said it was highly likely that mRNA vaccines would have the ultimate power to fight the coronavirus that causes Covid-19.“The technology is fast, potent and induces longer immunity, from cellular to humoral immunity,” Gao said, referring to anitbody-mediated immunity.“You are the heavyweights of the industry. I hope you will give thought tonight about whether your company should make a transition and whether you should start to make arrangements to work on mRNA vaccines.”Until the United States approved the Pfizer-BioNTech vaccine for emergency use last month, the shots used on people were mostly a safely weakened version of the virus, which triggered the human body to make antibodies to fight the disease proper.More advanced vaccines revolved around injecting part of the pathogen, such as a protein or sugar, to induce an immune response.The mRNA vaccines take a different approach altogether – delivering instructions to cells to make useful proteins.These formulas rely human cells decoding genetic material from the virus and making proteins to fight it. The material, synthetic mRNA, is wrapped in an oily bubble coating made of lipid nanoparticles to be delivered into the human body.Once in the body, the material fuses to cells and the cell’s molecules decode the genome sequence to build spike proteins, which train the human body to launch an immune response. The mRNA from the vaccines degrades in about 72 hours so it will not combine with human DNA. We can’t rule out risks with Covid-19 mRNA vaccines, top Chinese health official saysThe idea of using mRNA has been around for decades, but had got little beyond early stage human trials for cancer treatment or vaccines for the flu, Zika and rabies.Then Covid-19 happened and developers looked to unlock the power of mRNA.Xiang Zuoyun, chief strategy officer with Chinese vaccine developer Walvax Biotechnology, said this was the start of something new.“[mRNA] is excellent technology for developing viral vaccines in the future and it is very likely that, in 20 or 30 years, all vaccines will use it. The trend is quite obvious,” Xiang said. “I feel we are witnessing the beginning of a new vaccine era.”Xiang said biological companies should either acquire or foster the technical ability to seize the business opportunities presented by mRNA technology.One of the big advantages of synthetic mRNA is that it is much easier and quicker to produce in the lab than it is to inactivate or attenuate a virus. Moderna took only two months to design an mRNA vaccine and launch trials after Chinese scientists released the genome sequence of the coronavirus. And, in theory, mRNA can be directed to produce any protein, opening the door to make all kinds of vaccines for infectious diseases or even cancer.China has a handful of biotech start-ups specialising in mRNA vaccines and drugs, most of which were founded by scientists who gained their expertise overseas.One start-up is Stemirna Therapeutics, which has been given the green light for Covid-19 vaccine trials.Two other mRNA candidates jointly designed by Jiaotong and Fudan universities in Shanghai are in preclinical studies.Walvax is working on its ARCoVax vaccine with the Academy of Military Science and Suzhou Abogen Biosciences. Its candidate entered a phase 1B clinical trial in October and construction started on a factory for it in Yuxi, Yunnan province, last month. The goal is to be in production within eight months with an initial capacity of 120 million doses.Walvax has tried to shift more of its resources to mRNA vaccines by selling off some stakes in a company in the process of registering its HPV vaccine but this has been blocked by shareholders keen to reap the rewards of the earlier investment.Other companies are also trying to forge ahead. Last month Chongqing Zhifei Biological Products bought 10 per cent of Shenzhen Shenxin Biotechnology, one of China’s few start-ups developing mRNA vaccines for rare diseases, to increase its core competitiveness.Zhang Linqi, professor of medicine at Tsinghua University in Beijing, said mRNA was pushed to the forefront for the first time when clinical trials proved it to be safe and effective.“It has the advantage of being safe, quick to respond and precise in targeting the pathogen,” Zhang said. “If there is a future disease X, the mRNA technology will have a big advantage on the front line in fighting it.”However, mRNA developers still need to find ways to scale up production, reduce side effects and stablise the mRNA molecules, which can fall apart at room temperature and have to be transported under very cold conditions, according to Zhang.Heavyweights like Moderna and BioNTech have a head start in this area. Moderna established an mRNA-based pipeline for various infectious diseases, cancer, cardiovascular diseases and rare genetic diseases before the Covid-19 pandemic. It announced earlier this month that the company would start evaluating three candidates for seasonal flu vaccines and two candidates for HIV vaccines, and another as a vaccine against the Nipah virus. BioNTech also has a research pipeline of about 21 cancer drugs. Coronavirus: China breaks ground on mRNA vaccine plantPeng Yucai, founder of Zhuhai Lifanda Biotechnology, a biotech start-up specialising in mRNA vaccines and drugs, said good data from large trials of mRNA vaccines in other countries would have a positive influence on drug regulators in China, raising confidence in the new technology and increasing the prospects for such vaccines to be approved in the future.But the industry needs the government’s help to overcome a possible production bottleneck.“It’s a burgeoning industry, from the supply of raw materials to the supply of production equipment and it’s the case not only in China but also for the whole world,” Peng said. “The production chain will improve if the government is keen to develop the industry. It’s achievable.”More from South China Morning Post: * China’s coronavirus success shows it has caught up with West in some areas of innovation, Nobel laureate Paul Romer says * Coronavirus: Norway raises concern over Pfizer vaccine jabs for elderly as Australia seeks information * Coronavirus: experts say no reason for alarm over reports elderly people died after being given vaccine * US coronavirus deaths top 400,000 as Donald Trump leaves office * Chinese scientist’s spike protein research paves way for Covid-19 vaccineThis article Coronavirus: is China ready for the mRNA vaccine revolution? first appeared on South China Morning PostFor the latest news from the South China Morning Post download our mobile app. Copyright 2021.

  • Prada drops Chinese TV star amid surrogacy scandal

    Luxury fashion house Prada has cut ties with a popular Chinese actress amid claims that she abandoned her children born to surrogates abroad after breaking up with her boyfriend.

  • Trump leaves White House, skipping Biden inauguration

    US President Donald Trump left the White House for the final time on Wednesday, heading by helicopter to a nearby military base where he will fly to Florida, skipping the inauguration of successor Joe Biden in an extraordinary break with tradition.

  • Zidane says he still has players' backing after Real Madrid cup humiliation

    Zinedine Zidane insisted his players still believe in him after Real Madrid suffered an embarrassing defeat by third-tier side Alcoyano in the Copa del Rey on Wednesday.

  • French-Irish teen's family to challenge Malaysian inquest ruling

    The family of a French-Irish teenager will challenge an inquest ruling that she died by misadventure after vanishing in the Malaysian jungle while on holiday, their lawyer said Thursday.

  • Brazil may face shortages of China’s Covid-19 vaccine amid strained ties

    Brazil could soon face shortages of a Chinese coronavirus vaccine due to delays in the export of key ingredients, and local politicians are concerned that strained ties with Beijing may be a factor holding up shipments.CoronaVac, produced by Sinovac Biotech Ltd, won approval for emergency use from Brazil’s health regulator Anvisa on Sunday. The first health professionals were vaccinated on Monday in the state of São Paulo, making CoronaVac the first and for now only vaccine available in the country.The São Paulo government has ordered 46 million doses of the vaccine, with 6 million doses made available after the regulator’s approval. However, this batch will run out in a few weeks and Beijing has not yet approved shipment of ingredients needed to make more.Get the latest insights and analysis from our Global Impact newsletter on the big stories originating in China. Explainer | What do the Sinovac coronavirus vaccine efficacy results mean?Dimas Covas, head of the Butantan Institute in São Paulo that conducted CoronaVac’s largest phase 3 clinical trials, said in a news conference on Monday that the delay was a bureaucratic issue.The next day he asked Brazilian President Jair Bolsonaro to intervene, though the president has previously criticised CoronaVac, calling it the vaccine of “death and disablement”, and attacked China over the cause of the pandemic.“If the vaccine [CoronaVac] is now Brazil’s, may our president have the dignity to defend it and solicit the support of his foreign ministry in discussions with the Chinese government,” Covas said.Brazilian politicians are concerned the attacks on China by Bolsonaro and his allies will discourage Beijing’s cooperation.Rodrigo Maia, president of Brazil’s Chamber of Deputies, a federal legislative body, said on Tuesday he would meet Chinese ambassador Yang Wanming to discuss the shipment delays, but noted the lack of goodwill between the two sides.“The Brazilian government has stymied a relationship with China. We need to at least know what is happening, what is the reason for the active ingredients not reaching Brazil,” he said.An estimated 8.5 million of Brazil’s 210 million people have been infected with the coronavirus, and the country has the world’s second-highest death toll with more than 211,000.In April, Eduardo Bolsonaro, the president’s son, retweeted a reference to Covid-19 as the “Chinese virus”, a term that angered Beijing when used by US President Donald Trump in reference to the first outbreak of the disease in the central China city of Wuhan.In response, China’s consul general in Rio de Janeiro, Li Yang, wrote an editorial in O Globo newspaper defending Beijing’s handling of the outbreak. He asked the president’s son: “Have you been brainwashed by the United States and are now following them like cattle in opposing China?”The vaccine has become a factor in Brazil’s presidential election next year, with São Paulo governor João Doria one of Bolsonaro’s main challengers. In October, Bolsonaro vetoed a deal between the health ministry and Doria’s São Paulo state government to purchase CoronaVac doses.Separately, Bolsonaro issued a decree in August to set aside US$356 million to buy and eventually produce 100 million doses of another vaccine jointly developed by Oxford University and pharmaceutical company AstraZeneca.That product has also received emergency use approval from Brazil’s health regulator, but a plan to import 2 million doses fell through due to a lack of export approvals from India, where it is manufactured.Besides the problems in India, AstraZeneca’s Brazilian partner Fiocruz said in a note to Brazil’s Federal Public Ministry on Tuesday there was also a shortage of active ingredients due to export delays in China, which could affect the planned early February delivery date.This means Brazil must rely on CoronaVac for its immediate nationwide immunisation programme, confirming fears the country has not secured enough doses of different vaccines.São Paulo has about 1.5 million doses of the Chinese-made vaccine while a portion of the other 4.5 million are being distributed to 10 other states by the federal government.Butantan head Dimas Covas criticised Bolsonaro for his opposition to CoronaVac on Tuesday at an inoculation site in São Paulo.“Until Sunday the vaccine was our president’s number one enemy,” he said. “The vaccine was worthless because it was from China; just nonsense from someone who had not the slightest idea.”More from South China Morning Post: * China’s Sinovac defends Brazil results but regulators to look hard at data * What do the Sinovac coronavirus vaccine efficacy results mean? * Coronavirus: Brazil finds China’s Sinovac vaccine to be less effective than previous data showsThis article Brazil may face shortages of China’s Covid-19 vaccine amid strained ties first appeared on South China Morning PostFor the latest news from the South China Morning Post download our mobile app. Copyright 2021.

  • Man who trapped pregnant woman in lift and stroked her belly jailed 9 months

    The man molested the woman, pressing his body to her and rubbed her belly several times after she told him she was pregnant. 

  • Home Loans: SIBOR Rate vs Fixed Deposit Home Rate (FHR) Loans

    What is SIBOR? How does it compare to Fixed Deposit Home Rate (FHR) loans? Here’s a summary to help you compare between housing loans in Singapore and decide which is better. There are several types of home loans in the Singapore market today, namely Singapore […] The post Home Loans: SIBOR Rate vs Fixed Deposit Home Rate (FHR) Loans appeared first on SingSaver Blog - We Compare, You Save.

  • Ethiopians flex military muscle during Orthodox Epiphany holiday

    Outside a centuries-old stone church in the northern Ethiopian city of Gondar, a drama troupe performed skits hailing the military defeat of the former leaders of the country's Tigray region.

  • Hong Kong and Changi lose status as Asia’s busiest airports

    Hong Kong no longer has the busiest airport for international traffic in Asia after the coronavirus pandemic wiped out travel, leaving South Korea’s Incheon International Airport in top spot.

  • ‘Mike Pompeo was the best ever’: China’s Wolf Warriors are tweeting again

    A Chinese diplomat in Brazil has mocked Mike Pompeo on Twitter, calling him the best US secretary of state ever, as he prepares to leave office.“You made great contributions in dividing US people and uniting Chinese people, destroying US image and making China greater!” Li Yang, the Chinese consul general in Rio de Janeiro, tweeted on Tuesday, adding that he hated to say goodbye to him.Zhao Lijian, the Chinese foreign ministry spokesman and an outspoken Wolf Warrior diplomat, liked the tweet.Get the latest insights and analysis from our Global Impact newsletter on the big stories originating in China.> Mike, You are the best secretary of state ever in the US history. You made great contributions in dividing US people and uniting Chinese people, destroying US image and making China greater! I hate to say goodbye to you! @SecPompeo, @mikepompeo> > — Li Yang (@CGChinaLiYang) January 19, 2021Li, who has 1,900 followers, has begun the year with a barrage of tweets attacking the United States and occasionally Britain, including gloating about the failures of both nations’ coronavirus containment efforts.Two days before his Pompeo tweet, he wrote of US President Donald Trump: “Donald, look at your graduation results: trade war: failed; economy recovery, failed; fighting against coronavirus: failed; re-election campaign: failed; MAGA: question mark!”Joe Biden will replace Trump when he is inaugurated as the 46th president of the US on Wednesday.Li’s tweets continued the harder line adopted by Chinese diplomats towards the US with ties between the nations at their lowest point in decades, for which they have been described as Wolf Warriors. Wolf Warriors in the West: how China’s diplomats are taking to TwitterAhead of the change of president, Biden’s secretary of state nominee Antony Blinken said Trump had been right to take a tougher approach to China.Blinken’s comments came hours after Pompeo on Tuesday announced the Trump administration’s new assessment that China was committing crimes against humanity and genocide against Uygurs and other predominantly Muslim ethnic minority groups in China’s far-western Xinjiang region.The secretary of state had himself posted a barrage of tweets over the weekend lambasting China’s ruling Communist Party for matters including Hong Kong, Taiwan, Xinjiang and the initial handling of the coronavirus outbreak.Nationalistic Chinese tabloid Global Times hit back at Pompeo on Sunday, branding him a “lunatic”, after Chinese state media previously called him evil and insane for repeating the conspiracy theory that the coronavirus came from a laboratory in Wuhan, where the outbreak was first reported.Li, the diplomat in Brazil, had previously made headlines for writing an article making an unsubstantiated accusation that the Covid-19 outbreak in the US could be linked to a military lab in Maryland.Liu Weidong, a US affairs expert from the Chinese Academy of Social Sciences, said the war of words may be toned down in the early days of the Biden administration.“China won’t anger the Biden administration at a time when bilateral relations might be adjusted for better,” Liu said. “And without Pompeo, the Biden administration would not be that aggressive towards China, even though containing Chinese influence is still their primary goal.”More from South China Morning Post: * US declares China has committed genocide in its treatment of Uygurs in Xinjiang * US sanctions Chinese officials, executives over ‘coercive behaviour’ in South China Sea * Want to be a Chinese diplomat? Developers have a program that emulates China’s ‘Wolf Warrior’ rhetoricThis article ‘Mike Pompeo was the best ever’: China’s Wolf Warriors are tweeting again first appeared on South China Morning PostFor the latest news from the South China Morning Post download our mobile app. Copyright 2021.

  • Two separate tuberculosis clusters of 18 cases linked to Bedok betting centre found: MOH

    Two separate tuberculosis clusters involving 18 people who had prolonged exposure at the Singapore Pools Bedok Betting Centre have been identified.

  • Pogba fires Man Utd back to Premier League summit

    Paul Pogba produced a moment of magic as Manchester United came from behind to beat Fulham 2-1 and reclaim the Premier League lead on Wednesday, ending Manchester City's short stay at the top.

  • Israel rights group breaks taboo with 'apartheid' tag

    An Israeli non-governmental organisation has accused the Jewish state of "apartheid" in its treatment of Palestinians -- a taboo-breaking move that has seen its representatives banned from speaking in schools.